APA (7th ed.) Citation

A, B., F, C., A, O., N, S., KJ, R., V, A., . . . N, O. (2026). Immune landscape characterization of neurofibromas with atypical features in Neurofibromatosis1 reveals PD-1 and the Tim-3/Galectin-9 pathway as potential therapeutic targets. Acta neuropathologica communications, 14(1), . https://doi.org/10.1186/s40478-026-02310-1

Chicago Style (17th ed.) Citation

A, Brunet, et al. "Immune Landscape Characterization of Neurofibromas with Atypical Features in Neurofibromatosis1 Reveals PD-1 and the Tim-3/Galectin-9 Pathway as Potential Therapeutic Targets." Acta Neuropathologica Communications 14, no. 1 (2026). https://doi.org/10.1186/s40478-026-02310-1.

MLA (9th ed.) Citation

A, Brunet, et al. "Immune Landscape Characterization of Neurofibromas with Atypical Features in Neurofibromatosis1 Reveals PD-1 and the Tim-3/Galectin-9 Pathway as Potential Therapeutic Targets." Acta Neuropathologica Communications, vol. 14, no. 1, 2026, https://doi.org/10.1186/s40478-026-02310-1.